Related references
Note: Only part of the references are listed.The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
Ji Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness
Hidetaka Shima et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Expression and role of long non-coding RNA H19 in carcinogenesis
Hisashi Yoshimura et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression
Yuka Asano et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
A Minimal lncRNA-mRNA Signature Predicts Sensitivity to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Qian Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant Check triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway
Jiguang Han et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process
Hongli Gao et al.
ONCOTARGETS AND THERAPY (2018)
Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
Wenyong Tan et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Regulation of Human Breast Cancer by the Long Non-Coding RNA H19
Jordan Collette et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152
Zhen Li et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2017)
Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
Miaomiao Tao et al.
MEDICINE (2017)
A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer
Gen Wang et al.
TRANSLATIONAL ONCOLOGY (2017)
A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer
Raul Garcia-Vazquez et al.
TUMOR BIOLOGY (2017)
H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance
Fei Peng et al.
CELL DEATH & DISEASE (2017)
Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies
Tessa G. Steenbruggen et al.
DRUGS (2017)
Emerging concepts in liquid biopsies
Samantha Perakis et al.
BMC MEDICINE (2017)
Patient -Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple -Negative Breast Cancer
Francesca Riva et al.
CLINICAL CHEMISTRY (2017)
Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer
Gaiane M. Rauch et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer
Kaijiong Zhang et al.
CANCER BIOMARKERS (2016)
Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer
Maire-Caitlin Casey et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Progress in the clinical detection of heterogeneity in breast cancer
Jun-Long Song et al.
CANCER MEDICINE (2016)
Triple-negative Breast Carcinoma: Morphologic and Molecular Subtypes
Shikha Bose
ADVANCES IN ANATOMIC PATHOLOGY (2015)
Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials
Sibylle Loibl et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study
D. Balmativola et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Peter A. Fasching et al.
BMC CANCER (2011)
Locally advanced and inflammatory breast cancer
Stephen Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1
N Berteaux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Share Paper
